Aivita Group Inc.

As of September 30, 2016, Aivita Group Inc. has 82.27M shares outstanding.

These figures are as of September 30, 2016. The price-to-sales ratio is 19.34, and the price-to-book ratio stands at -4.71.

These figures are as of September 30, 2016. The EV/Sales ratio of 17.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Aivita Group Inc. trades at an EV/FCF ratio of 51.06, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of September 30, 2016, Aivita Group Inc. maintains a current ratio of 9.11, meaning it holds 9.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.50, indicating elevated leverage, while an interest coverage ratio of -39.58 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2016. Return on assets (ROA) is negative at -17.16, reflecting losses generated across the asset base. Inventory turnover of 15.45 indicates how many times Aivita Group Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2016, Aivita Group Inc. posted a gross margin of 5.58, reflecting its pricing power and cost economics. The operating margin of -82.78 and net profit margin of -77.80 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2016. Free cash flow yield is negative at -0.10: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -11.71, meaning Aivita Group Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of September 30, 2016, Aivita Group Inc. has an Altman Z-Score of 23.96, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.